Two former Pfizer executives said they will not be involved with activist investor Starboard Value, which reportedly wants ...
(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...
In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...
Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.
On Monday, Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga ...
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...
London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...
Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback